APA (7th ed.) Citation

Jacobsen, E., Plant, A., Redd, R., Armand, P., McDonough, M., Ihuoma, U., . . . Freedman, A. (2024). A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma. Leukemia & Lymphoma, 65(12), 1864. https://doi.org/10.1080/10428194.2024.2381651

Chicago Style (17th ed.) Citation

Jacobsen, Eric, et al. "A Phase I Trial of Vaccination with Lethally Irradiated Lymphoma Cells Admixed with Granulocyte-macrophage Colony-stimulating Factor Secreting K562 Cells for the Treatment of Follicular Lymphoma." Leukemia & Lymphoma 65, no. 12 (2024): 1864. https://doi.org/10.1080/10428194.2024.2381651.

MLA (9th ed.) Citation

Jacobsen, Eric, et al. "A Phase I Trial of Vaccination with Lethally Irradiated Lymphoma Cells Admixed with Granulocyte-macrophage Colony-stimulating Factor Secreting K562 Cells for the Treatment of Follicular Lymphoma." Leukemia & Lymphoma, vol. 65, no. 12, 2024, p. 1864, https://doi.org/10.1080/10428194.2024.2381651.